4//SEC Filing
Eastling Thomas Wilson 4
Accession 0001140361-25-014601
CIK 0001124105other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 5:27 PM ET
Size
6.6 KB
Accession
0001140361-25-014601
Insider Transaction Report
Form 4
Eastling Thomas Wilson
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2025-04-16−15,000→ 299,652 totalExercise: $6.93Exp: 2033-10-31→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2025-04-16$6.93/sh+15,000$103,950→ 15,000 total
Footnotes (1)
- [F1]These options are vested in full.
Documents
Issuer
GYRE THERAPEUTICS, INC.
CIK 0001124105
Entity typeother
Related Parties
1- filerCIK 0001958487
Filing Metadata
- Form type
- 4
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 5:27 PM ET
- Size
- 6.6 KB